We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

92 hedge funds and large institutions have $589M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 12 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

577% more call options, than puts

Call options by funds: $1.33M | Put options by funds: $197K

300% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 12

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

30% more capital invested

Capital invested by funds: $453M → $589M (+$136M)

11% more funds holding

Funds holding: 83 → 92 (+9)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
92
Holders Change
+9
Holders Change %
+10.84%
% of All Funds
2.67%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
48
Reduced
12
Closed
13
Calls
$1.33M
Puts
$197K
Net Calls
+$1.14M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
+$29.9M
2
PAI
Palo Alto Investors
California
+$24.1M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$23.6M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$19.1M
5
State Street
State Street
Massachusetts
+$17.6M

Top Sellers

Rank Fund Capital Flow
1
CCI
Columbus Circle Investors
-$10.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.95M
3
IA
Investor AB
Sweden
-$3.54M
4
OAM
Oxford Asset Management
United Kingdom
-$2.76M
5
WC
Wexford Capital
Florida
-$912K
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$4.4M – – –
AGA
27
Altrinsic Global Advisors
Connecticut
$4.23M – – –
AC
28
Ascend Capital
California
$3.01M -$87.5K -2,109 -3%
BNP Paribas Asset Management
29
BNP Paribas Asset Management
France
$2.99M +$3.33M +80,296 New
SAM
30
Senzar Asset Management
New York
$2.95M +$3.28M +79,000 New
FWIA
31
Fort Washington Investment Advisors
Ohio
$2.82M +$3.13M +75,510 New
DCM
32
Driehaus Capital Management
Illinois
$2.56M +$818K +19,730 +40%
SM
33
Sabby Management
Florida
$2.47M +$2.75M +66,200 New
BCM
34
BBT Capital Management
Texas
$2.43M – – –
Geode Capital Management
35
Geode Capital Management
Massachusetts
$2.36M +$950K +22,901 +57%
FM
36
Forward Management
California
$2.11M +$579K +13,948 +26%
TCIM
37
TIAA CREF Investment Management
New York
$2.06M +$569K +13,730 +33%
EI
38
EAM Investors
California
$2.06M -$208K -5,018 -8%
GACM
39
Green Arrow Capital Management
New York
$2.05M +$2.28M +55,000 New
Alyeska Investment Group
40
Alyeska Investment Group
Illinois
$1.98M +$2.2M +53,092 New
TAM
41
Tocqueville Asset Management
New York
$1.8M +$2M +48,220 New
Deutsche Bank
42
Deutsche Bank
Germany
$1.78M +$1.21M +29,113 +156%
Renaissance Technologies
43
Renaissance Technologies
New York
$1.54M +$1.71M +41,200 New
RFC
44
Russell Frank Company
Washington
$1.5M -$471K -11,364 -26%
Wells Fargo
45
Wells Fargo
California
$1.45M +$1.52M +36,593 +1,738%
Mackenzie Financial
46
Mackenzie Financial
Ontario, Canada
$1.43M +$1.29M +31,061 +423%
BIM
47
BlackRock Investment Management
Delaware
$1.21M +$154K +3,716 +13%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$1.03M -$849K -20,461 -42%
GGHC
49
Gilder Gagnon Howe & Co
New York
$1.02M -$375K -9,030 -25%
Charles Schwab
50
Charles Schwab
California
$1M +$245K +5,895 +28%
1
2
3 4 5

KYTH Hedge Fund Activity: Q4 2013 in Review

92 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2013, worth a combined $589M — up 30% from $453M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new KYTH positions and 13 closed out — a net gain of 10 holders — while 48 added to existing stakes and 12 trimmed.

The largest buyer was Waddell & Reed Financial, adding an estimated $29.9M. The largest seller was Columbus Circle Investors, exiting entirely with an estimated $10.7M sold.

  • 92 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2013, up from 83 in Q3 2013.
  • Funds reported $589M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2013, up 30% quarter-over-quarter.
  • 23 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2013 and 13 closed out, a net change of +10 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q4 2013 was Waddell & Reed Financial, an estimated $29.9M added.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2013 was Columbus Circle Investors, an estimated $10.7M sold.

Based on aggregated 13F filings for Q4 2013.